Identifying Biomarkers for Biological Age: Geroscience and the ICFSR Task Force
暂无分享,去创建一个
[1] Brian R. Kotajarvi,et al. The senescence-associated secretome as an indicator of age and medical risk. , 2020, JCI insight.
[2] F. Sierra. Geroscience and the Coronavirus Pandemic: The Whack‐a‐Mole Approach is not Enough , 2020, Journal of the American Geriatrics Society.
[3] D. Cucinotta,et al. WHO Declares COVID-19 a Pandemic , 2020, Acta bio-medica : Atenei Parmensis.
[4] Qiang Zhou,et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.
[5] J. Beard,et al. Linking Geroscience and Integrated Care to Reinforce Prevention , 2020, The Journal of Prevention of Alzheimer's Disease.
[6] M. Levine,et al. A roadmap to build a phenotypic metric of ageing: insights from the Baltimore Longitudinal Study of Aging , 2020, Journal of internal medicine.
[7] J. Morley,et al. Editorial: COVID-19 and Older Adults. , 2020, The journal of nutrition, health & aging.
[8] N. Fazilleau,et al. Revisiting the Hallmarks of Aging to Identify Markers of Biological Age , 2019, The Journal of Prevention of Alzheimer's Disease.
[9] Toshiko Tanaka,et al. Measuring biological aging in humans: A quest , 2019, Aging cell.
[10] L. Rodríguez-Mañas,et al. ICFSR Task Force Perspective on Biomarkers for Sarcopenia and Frailty , 2019, The Journal of Frailty & Aging.
[11] G. Duque,et al. Osteosarcopenia: A case of geroscience , 2019, Aging medicine (Milton (N.S.W)).
[12] L. Rodríguez-Mañas,et al. Increased levels of soluble Receptor for Advanced Glycation End-products (RAGE) are associated with a higher risk of mortality in frail older adults. , 2019, Age and ageing.
[13] S. Bandinelli,et al. Associations of fat‐soluble micronutrients and redox biomarkers with frailty status in the FRAILOMIC initiative , 2019, Journal of cachexia, sarcopenia and muscle.
[14] J. Tegnér,et al. Associations of Plasma 3-Methylhistidine with Frailty Status in French Cohorts of the FRAILOMIC Initiative , 2019, Journal of clinical medicine.
[15] M. Cesari,et al. Frailty and Intrinsic Capacity: Two Distinct but Related Constructs , 2019, Front. Med..
[16] Gustavo Duque,et al. Current and emerging biomarkers of frailty in the elderly , 2019, Clinical interventions in aging.
[17] S. Bandinelli,et al. Patterns of circulating fat-soluble vitamins and carotenoids and risk of frailty in four European cohorts of older adults , 2019, European Journal of Nutrition.
[18] M. Kaeberlein. Translational geroscience: A new paradigm for 21st century medicine. , 2017, Translational medicine of aging.
[19] R. de Cabo,et al. A Comparison of Two Mouse Frailty Assessment Tools , 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.
[20] R. Kohanski,et al. Geroscience and the trans-NIH Geroscience Interest Group, GSIG , 2017, GeroScience.
[21] L. Rodríguez-Mañas. Use of Biomarkers. , 2015, The Journal of frailty & aging.
[22] A. Sinclair,et al. In Search of ‘Omics'-Based Biomarkers to Predict Risk of Frailty and Its Consequences in Older Individuals: The FRAILOMIC Initiative , 2015, Gerontology.
[23] E. Schadt,et al. Geroscience: Linking Aging to Chronic Disease , 2014, Cell.
[24] Manuel Serrano,et al. The Hallmarks of Aging , 2013, Cell.